Less than a year after Affymetrix bought eBioscience, the array vendor is finding ways to combine its background in microarray and branched-DNA genotyping and expression with eBio's flow cytometry reagents and multiplex immunoassay portfolios.
Affymetrix this week reported a slight uptick in its second-quarter revenues, which increased 3 percent to $66.4 million from $64.7 million in the year-ago period, beating the average analyst estimate of $65.6 million.
NetBio has been awarded US Patent No. 8,018,593, "Integrated nucleic acid analysis."
Eugene Tan, Heung Lam, Valery Bogdanov, Gregory Kellogg, John Wright, Ulrich Thomann, and Richard Selden are named as inventors on the patent.
Acknowledging the challenges the firm faces and admitting it has been "slow to respond to technology changes" in the market, Frank Witney said the firm still has some opportunities to restore growth — if it positions its products correctly.